Fujun Dai
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
-
- Polyamine Metabolism and Applications
- Angiogenesis and VEGF in Cancer
- Natural product bioactivities and synthesis
- Synthesis and bioactivity of alkaloids
Papers in
-
- Polyamine Metabolism and Applications 6
- Angiogenesis and VEGF in Cancer 6
- Mechanisms of cancer metastasis 3
- Histone Deacetylase Inhibitors Research 2
- Synthesis and bioactivity of alkaloids 2
-
- Synthesis and biological activity 8
- Co-authors
- Zhengfang Yi (9 shared papers)Mingyao Liu (7 shared papers)Songqiang Xie (14 shared papers)Yanmin Dong (4 shared papers)Chaojie Wang (12 shared papers)Yajuan Song (3 shared papers)Li Lai (3 shared papers)Yihua Chen (6 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Bioorganic Chemistry (2 papers)Journal of Medicinal Chemistry (2 papers)Phytomedicine (2 papers)Angiogenesis (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Fujun Dai
27 papers receiving 828 citations
Peers
Comparison fields: 5 of 70
- Toxicology 39
- Molecular Biology 422
- Oncology 127
- Pharmacology 71
- Organic Chemistry 145
Countries citing papers authored by Fujun Dai
This map shows the geographic impact of Fujun Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fujun Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fujun Dai more than expected).
Fields of papers citing papers by Fujun Dai
This network shows the impact of papers produced by Fujun Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fujun Dai. The network helps show where Fujun Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Fujun Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 115 | |
| 2 | 2012 | 89 | |
| 3 | 2017 | 86 | |
| 4 | 2011 | 75 | |
| 5 | 2012 | 72 | |
| 6 | 2014 | 38 | |
| 7 | 2014 | 36 | |
| 8 | 2017 | 34 | |
| 9 | 2016 | 31 | |
| 10 | 2014 | 29 | |
| 11 | 2018 | 29 | |
| 12 | 2017 | 24 | |
| 13 | 2021 | 22 | |
| 14 | 2017 | 19 | |
| 15 | 2021 | 19 | |
| 16 | 2014 | 16 | |
| 17 | 2023 | 14 | |
| 18 | 2024 | 14 | |
| 19 | 2018 | 13 | |
| 20 | 2018 | 13 |
About Fujun Dai
Fujun Dai is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Toxicology and Cancer Research, having authored 30 papers that have together received 837 indexed citations. Recurring topics across this work include Synthesis and biological activity (8 papers), Polyamine Metabolism and Applications (6 papers), Angiogenesis and VEGF in Cancer (6 papers), Mechanisms of cancer metastasis (3 papers), Autophagy in Disease and Therapy (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Synthesis and bioactivity of alkaloids (2 papers). The work is most often cited by research in Toxicology (39 citations), Molecular Biology (422 citations), Oncology (127 citations), Pharmacology (71 citations) and Organic Chemistry (145 citations). Fujun Dai has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhengfang Yi, Mingyao Liu, Songqiang Xie, Yanmin Dong, Chaojie Wang, Yajuan Song, Li Lai, Yihua Chen, Yuxia Wang and Binbin Lu. Their work appears in journals such as Frontiers in Oncology, Bioorganic Chemistry, Journal of Medicinal Chemistry, Phytomedicine and Angiogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.